What is 10x Genomics, Inc.'s total revenue?

10x Genomics, Inc. (TXG) reported total revenue of $150.84M in Q1 2026.

How has 10x Genomics, Inc.'s total revenue changed year-over-year?

10x Genomics, Inc.'s total revenue decreased by 2.6% year-over-year, from $154.88M to $150.84M.

What is the long-term trend for 10x Genomics, Inc.'s total revenue?

Over 4 years (2021 to 2025), 10x Genomics, Inc.'s total revenue has grown at a 7.0% compound annual growth rate (CAGR), from $490.49M to $642.82M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

10x Genomics, Inc. TXG Total Revenue

Total Revenue at other companies

TEC

Bio-TechneTECH

$311.42M-1.5%

BrukerBRKR

$823.4M+2.7%

IlluminaILMN

$1.09B+4.8%

Twist Bioscience CorporationTWST

$110.72M+19.3%

RevvityRVTY

$711.12M+7.0%

Bio-Rad LaboratoriesBIO

$592.1M+1.1%

Segments

By product

See full

Products and services revenue$149.9M+8.8%

Chromium$88.89M+5.7%

Services$8.83M+15.4%

Spatial$6.04M-32.2%

Single Cell$5.22M-11.7%

License and royalty revenue$947K-94.4%

By geography

See full

Europe, Middle East and Africa$36.85M+15.5%

Asia-Pacific (excluding China)$18.06M+16.2%

Americas (excluding United States)$3.41M-9.2%

Other financials

Income statement

See full

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Enterprise value$4B+199%

P/S6.9×+4.1×

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s total revenue?: 10x Genomics, Inc. (TXG) reported total revenue of $150.84M in Q1 2026.
How has 10x Genomics, Inc.'s total revenue changed year-over-year?: 10x Genomics, Inc.'s total revenue decreased by 2.6% year-over-year, from $154.88M to $150.84M.
What is the long-term trend for 10x Genomics, Inc.'s total revenue?: Over 4 years (2021 to 2025), 10x Genomics, Inc.'s total revenue has grown at a 7.0% compound annual growth rate (CAGR), from $490.49M to $642.82M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.